Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(1.83)
# 2,993
Out of 4,784 analysts
82
Total ratings
25.61%
Success rate
-5.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MURA Mural Oncology | Maintains: Buy | $18 → $6 | $1.18 | +408.47% | 5 | Mar 26, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $26.42 | +183.88% | 11 | Mar 25, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.52 | +294.74% | 9 | Mar 21, 2025 | |
| IBRX ImmunityBio | Reiterates: Buy | $8 | $3.14 | +154.78% | 1 | Mar 13, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $75 → $50 | $5.52 | +805.80% | 1 | Mar 12, 2025 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $1.03 | +1,356.31% | 16 | Mar 12, 2025 | |
| ENGN enGene Holdings | Reiterates: Buy | $25 | $4.30 | +481.40% | 2 | Mar 11, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $40 → $36 | $8.07 | +346.10% | 13 | Feb 26, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $40 → $50 | $32.84 | +52.25% | 13 | Nov 26, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.32 | +203.03% | 11 | Nov 11, 2024 |
Mural Oncology
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $1.18
Upside: +408.47%
CG Oncology
Mar 25, 2025
Reiterates: Buy
Price Target: $75
Current: $26.42
Upside: +183.88%
Erasca
Mar 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.52
Upside: +294.74%
ImmunityBio
Mar 13, 2025
Reiterates: Buy
Price Target: $8
Current: $3.14
Upside: +154.78%
Corbus Pharmaceuticals Holdings
Mar 12, 2025
Reiterates: Buy
Price Target: $75 → $50
Current: $5.52
Upside: +805.80%
Werewolf Therapeutics
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.03
Upside: +1,356.31%
enGene Holdings
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $4.30
Upside: +481.40%
Day One Biopharmaceuticals
Feb 26, 2025
Maintains: Buy
Price Target: $40 → $36
Current: $8.07
Upside: +346.10%
Scholar Rock Holding
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $32.84
Upside: +52.25%
Ikena Oncology
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.32
Upside: +203.03%